Effects on Symptoms of Agitation and Depression in Persons With Dementia Participating in Robot-Assisted Activity: A Cluster-Randomized Controlled Trial

Effects on Symptoms of Agitation and Depression in Persons With Dementia Participating in Robot-Assisted Activity: A Cluster-Randomized Controlled Trial
复制标题

DOI:
10.1016/j.jamda.2015.05.002
复制
发表时间:
2015-10-01
影响因子:
7.6
通讯作者:
Ihlebaek, Camilla
Ihlebaek, Camilla
中科院分区:
医学1区
文献类型:
--
作者:
Joranson, Nina;Pedersen, Ingeborg;Ihlebaek, Camilla

文献摘要

被引文献

相似文献

目的:要检查的影响,在疗养院居民的躁动和抑郁症状中重度痴呆症参与机器人辅助组活动与机器人密封Paro.Design:一个集群随机对照试验。在2013年至2014年的3个干预期内,将10个养老院单位随机分为机器人辅助干预组或对照组,正常治疗。设置:挪威东部3个县的养老院的10个适应单位。60名居民(67%为女性,年龄范围62-95岁),在适应性疗养院单元中诊断为痴呆或认知障碍(简易精神状态检查评分低于25/30).干预:在12周的过程中,与Paro的小组会议在疗养院的单独房间中进行,每周两次,每次30分钟。当地护士进行了培训,进行intervention.Measurements:参与者进行了基线测量(T0)评估认知状态,定期服药,激越(BARS),抑郁症(CSDD)。在干预结束时(T1)和随访时(干预结束后3个月)(T2)重复收集数据。混合模型被用来测试治疗和时间effectives.Results:统计学显着差异的变化,发现从T0到T2组之间的激越和抑郁。虽然干预组的症状有所下降,但对照组的症状却朝着相反的方向发展。躁动的效应估计值为-5.51,CI 0.06-10.97,P = 0.048,抑郁为-3.88,CI 0.43-7.33,P = 0.028。T0 ~ T1组间激越、抑郁症状的变化无显著性差异。结论:在活动组中使用帕罗对老年痴呆患者的抑郁、激越症状有远期疗效。帕罗可能是一个合适的非药物治疗神经精神症状,并应被视为一个有用的工具,在临床实践中。(C)2015年AMDA -急性后和长期护理医学协会。
Objectives: To examine effects on symptoms of agitation and depression in nursing home residents with moderate to severe dementia participating in a robot-assisted group activity with the robot seal Paro.Design: A cluster-randomized controlled trial. Ten nursing home units were randomized to either robot-assisted intervention or a control group with treatment as usual during 3 intervention periods from 2013 to 2014.Setting: Ten adapted units in nursing homes in 3 counties in eastern Norway.Participants: Sixty residents (67% women, age range 62-95 years) in adapted nursing home units with a dementia diagnosis or cognitive impairment (Mini-Mental State Examination score lower than 25/30).Intervention: Group sessions with Paro took place in a separate room at nursing homes for 30 minutes twice a week over the course of 12 weeks. Local nurses were trained to conduct the intervention.Measurements: Participants were scored on baseline measures (T0) assessing cognitive status, regular medication, agitation (BARS), and depression (CSDD). The data collection was repeated at end of intervention (T1) and at follow-up (3 months after end of intervention) (T2). Mixed models were used to test treatment and time effects.Results: Statistically significant differences in changes were found on agitation and depression between groups from T0 to T2. Although the symptoms of the intervention group declined, the control group's symptoms developed in the opposite direction. Agitation showed an effect estimate of -5.51, CI 0.06 -10.97, P = .048, and depression -3.88, CI 0.43-7.33, P = .028. There were no significant differences in changes on either agitation or depression between groups from T0 to T1.Conclusion: This study found a long-term effect on depression and agitation by using Paro in activity groups for elderly with dementia in nursing homes. Paro might be a suitable nonpharmacological treatment for neuropsychiatric symptoms and should be considered as a useful tool in clinical practice. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.